Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers.
Bianchini G, Pusztai L, Karn T, Iwamoto T, Rody A, Kelly C, Müller V, Schmidt S, Qi Y, Holtrich U, Becker S, Santarpia L, Fasolo A, Del Conte G, Zambetti M, Sotiriou C, Haibe-Kains B, Symmans WF, Gianni L.
Bianchini G, et al.
Breast Cancer Res. 2013;15(5):R86. doi: 10.1186/bcr3481.
Breast Cancer Res. 2013.
PMID: 24060333
Free PMC article.